New York was the only state to receive the highest mark on the ALS Association’s latest report cards, the association said.

A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

ALS took many things from columnist Juliet Taylor's late husband, Jeff, including the end of his career, which was ...

With the hold lifted, Amylyx can begin screening and enrolling for its Phase 1 LUMINA trial, which will test AMX0114 in ALS ...

Riluzole treatment and a diet containing high glycemic index foods interact 'synergistically' to slow ALS progression, ...

A study in Italy found ALS incidence and onset rose with living near arable crops (cereals, beans, root crops), and with ...

Caregiving for a husband with ALS can be taxing, says columnist Kristin Neva, which is why it's important to have things to ...

The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...

Half of ALS patients experience constipation, which is associated with faster progression and lower survival rates, per a ...

David Husman, a Chicago businessman, donated the money to advance an ALS and a neuroscience center where his wife had been ...

Eli Lilly partnership aims to identify new treatments for ALS based on antibodies from people with very slow disease ...